Armistice Capital, LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 24,844,725 9.200% | 24,003,030 (+2851.75%) | Filing |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 52,606 9.990% | 38,690 (+278.03%) | Filing |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 13,916 9.990% | 13,916 (New Position) | Filing |